PRESS-NEWS.org - Press Release Distribution
FREE PRESS RELEASES DISTRIBUTION

Oncotarget: MEK inhibitors relevant to SARS-CoV-2 infection

The @Oncotarget authors show a drug class-effect with MEKi to stimulate NK cells, inhibit inflammatory cytokines and block host-factors for SARS-CoV-2 infection leading also to suppression of SARS-CoV-2-S pseudovirus infection of human cells

Oncotarget: MEK inhibitors relevant to SARS-CoV-2 infection
2021-02-22
(Press-News.org) The cover for issue 46 of Oncotarget features Figure 6, "Establishment of a SARS-CoV-2 pseudovirus that expresses SPIKE protein variants on the envelope of a lentiviral core, infection of human airway epithelial cells or lung cancer cells, and demonstration of MEKi attenuation of infectivity on primary human cells," published in "MEK inhibitors reduce cellular expression of ACE2, pERK, pRb while stimulating NK-mediated cytotoxicity and attenuating inflammatory cytokines relevant to SARS-CoV-2 infection" by Zhou, et al. which reported that Natural Killer cells and innate-immune TRAIL suppress transformed and virally-infected cells.

In some human cells, remdesivir increases ACE2-promoter luciferase-reporter expression, ACE2 mRNA and protein, and ACE2 expression is attenuated by MEKi.

In serum-deprived and stimulated cells treated with remdesivir and MEKi we observed correlations between pRB, pERK, and ACE2 expression further supporting the role of proliferative state and MAPK pathway in ACE2 regulation.

Pseudotyped SARS-CoV-2 virus with a lentiviral core and SARS-CoV-2 D614 or G614 SPIKE protein on its envelope infected human bronchial epithelial cells, small airway epithelial cells, or lung cancer cells and MEKi suppressed infectivity of the pseudovirus.

The Oncotarget authors show a drug class-effect with MEKi to stimulate NK cells, inhibit inflammatory cytokines and block host-factors for SARS-CoV-2 infection leading also to suppression of SARS-CoV-2-S pseudovirus infection of human cells.

The Oncotarget authors show a drug class-effect with MEKi to stimulate NK cells, inhibit inflammatory cytokines and block host-factors for SARS-CoV-2 infection leading also to suppression of SARS-CoV-2-S pseudovirus infection of human cells

Dr. Wafik S. El-Deiry from The Brown University said, "Coronavirus 2 (SARS-CoV-2) infection progresses to a rapidly lethal adult respiratory distress syndrome (ARDS) associated with high mortality especially among the elderly or those with multiple comorbid conditions."

It is clear that while the host systemic inflammatory response makes patients critically ill, the host innate immune system including natural killer cells is involved in fighting and eliminating virally-infected cells.

Over the last 25 years the authors have studied this innate immune system pathway that the immune system uses to eliminate transformed and cancer cells as well as virally-infected cells.

Thus, their goal was to better understand and modulate the host immune response to increase the innate immune system early in SARS-CoV-2 infection while reducing the severe inflammation that occurs late in the disease course.

Since remdesivir has been shown to reduce hospitalization and may reduce mortality in patients with severe COVID-19 infection, they hypothesized that suppression of viral entry into cells through inhibition of ACE2 and TMPRSS2 would reduce the spread of SARS-CoV-2 infection in a given COVID-19- patient and this would allow the innate immune system and antivirals such as remdesivir to more effectively suppress early infection.

Their results suggest that MEK inhibitors, as a class, suppress host SARS-CoV-2 infectivity factors such as ACE2 and TMPRSS2, and that alone or in combination with remdesivir, there is innate immune system activity along with suppression of inflammatory cytokines and stimulation of Natural Killer cell activity.

The El-Deiry Research Team concluded in their Oncotarget Priority Research Paper that Based on the data in this manuscript it may be reasonable to consider further preclinical experiments as well as clinical translation of the MEKi results.

Some of the open questions include a more detailed understanding of how the MAPK pathway activates ACE2, more direct evidence for effects of MEKi on actual SARS-CoV-2 infectivity of human cells, and more evidence for their effects on COVID-19 infection spread in preclinical models.

In the clinic, it may be reasonable to test MEKi such as VS-6766 or trametinib in COVID-19 infected but less severely ill patients to test the idea that MEKi could keep the infection from getting worse while allowing the body?s NK cells and innate immune mechanisms to more effectively attack virally infected cells prior to severe infection.

Consideration could be given to evaluation of MEKi ?/ antiviral agents such as remdesivir given results suggesting potentially favorable drug interactions that may allow suppression of infectivity, suppression of inflammatory cytokines, stimulation of NK cell activity, and lack of suppression of TRAIL-mediated cytotoxicity.

These effects may help antiviral agents achieve more potent disease suppression to attenuate or block COVID-19 infection that may be of use as a therapeutic approach in patients with early or less severe COVID-19 disease.

Sign up for free Altmetric alerts about this article

DOI - https://doi.org/10.18632/oncotarget.27799

Full text - https://www.oncotarget.com/article/27799/text/

Correspondence to - Wafik S. El-Deiry - wafik@brown.edu

Keywords - ACE2, TMPRSS2, SARS-CoV-2, COVID-19, pseudovirus

About Oncotarget

Oncotarget is a biweekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology.

To learn more about Oncotarget, please visit https://www.oncotarget.com or connect with:

SoundCloud - https://soundcloud.com/oncotarget
Facebook - https://www.facebook.com/Oncotarget/
Twitter - https://twitter.com/oncotarget
LinkedIn - https://www.linkedin.com/company/oncotarget
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget/

Oncotarget is published by Impact Journals, LLC please visit http://www.ImpactJournals.com or connect with @ImpactJrnls


[Attachments] See images for this press release:
Oncotarget: MEK inhibitors relevant to SARS-CoV-2 infection

ELSE PRESS RELEASES FROM THIS DATE:

A dynamic forest floor

2021-02-22
Walk along the beach after a winter storm and you'll see a shore littered with wracks of giant kelp, some 30 to 40 feet long -- evidence of the storm's impact on coastal kelp forests. Less apparent to the casual beachgoer is what happens to the submarine forests after the storm's fury dies down. This is precisely the topic of a new study led by Raine Detmer(link is external), a graduate student at UC Santa Barbara. She developed a mathematical model describing the effects of severe storms on kelp forest ecosystems, particularly the seafloor, or benthic, communities. The research, published in Ecology (link is external), reveals an ecosystem whose variability is key to its diversity. Giant kelp ...

Researchers develop speedier network analysis for a range of computer hardware

2021-02-22
Graphs -- data structures that show the relationship among objects -- are highly versatile. It's easy to imagine a graph depicting a social media network's web of connections. But graphs are also used in programs as diverse as content recommendation (what to watch next on Netflix?) and navigation (what's the quickest route to the beach?). As Ajay Brahmakshatriya summarizes: "graphs are basically everywhere." Brahmakshatriya has developed software to more efficiently run graph applications on a wider range of computer hardware. The software extends GraphIt, a state-of-the-art graph programming language, to ...

Yale neurologists identify consistent neuroinflammatory response in ICH patients

2021-02-22
Understanding how the immune system responds to acute brain hemorrhage could open doors to identifying treatments for this devastating disease. However, up until now, there has been limited information on inflammation in the brain from human patients, especially during the first days after a hemorrhagic stroke. This led a team of researchers to partner with a large clinical trial of minimally-invasive surgery to tackle defining the human neuroinflammatory response in living patients. "Our goal was to find out, for the first time, how certain key cells of the immune system are activated when they enter the brain after a hemorrhage and how this may shift over the first week. This ...

NASA's Swift helps tie neutrino to star-shredding black hole

NASAs Swift helps tie neutrino to star-shredding black hole
2021-02-22
For only the second time, astronomers have linked an elusive particle called a high-energy neutrino to an object outside our galaxy. Using ground- and space-based facilities, including NASA's Neil Gehrels Swift Observatory, they traced the neutrino to a black hole tearing apart a star, a rare cataclysmic occurrence called a tidal disruption event. "Astrophysicists have long theorized that tidal disruptions could produce high-energy neutrinos, but this is the first time we've actually been able to connect them with observational evidence," said Robert Stein, a doctoral student at the German Electron-Synchrotron (DESY) research center in ...

Politics and the brain: Attention perks up when politicians break with party lines

Politics and the brain: Attention perks up when politicians break with party lines
2021-02-22
In a time of extreme political polarization, hearing that a political candidate has taken a stance inconsistent with their party might raise some questions for their constituents. Why don't they agree with the party's position? Do we know for sure this is where they stand? New research led by University of Nebraska-Lincoln political psychologist Ingrid Haas has shown the human brain is processing politically incongruent statements differently -- attention is perking up -- and that the candidate's conviction toward the stated position is also playing a role. In other words, there is a stronger neurological response happening when, for example, a Republican takes a position favorable to new taxes, ...

NYU Abu Dhabi researcher sheds new light on the psychology of radicalization

2021-02-22
Abu Dhabi, UAE, February 22, 2021: Learning more about what motivates people to join violent ideological groups and engage in acts of cruelty against others is of great social and societal importance. New research from Assistant Professor of Psychology at NYUAD Jocelyn Bélanger explores the idea of ideological obsession as a form of addictive behavior that is central to understanding why people ultimately engage in ideological violence, and how best to help them break this addiction. In the new study, END ...

Toddler sleep patterns matter

Toddler sleep patterns matter
2021-02-22
Establishing a consistent sleep schedule for a toddler can be one of the most challenging aspects of child rearing, but it also may be one of the most important. Research findings from a team including Lauren Covington, an assistant professor in the University of Delaware School of Nursing, suggest that children with inconsistent sleep schedules have higher body mass index (BMI) percentiles. Their findings, published in the Annals of Behavioral Medicine, suggest sleep could help explain the association between household poverty and BMI. "We've known for a while that physical activity and diet quality are very strong predictors of weight and BMI," said Covington, the lead author of the article. "I think it's really highlighting that ...

Medications for enlarged prostate linked to heart failure risk

2021-02-22
February 22, 2021 - Widely used medications for benign prostatic hyperplasia (BPH) - also known as enlarged prostate - may be associated with a small, but significant increase in the probability of developing heart failure, suggests a study in The Journal of Urology®, Official Journal of the American Urological Association (AUA). The journal is pub lished in the Lippincott portfolio by Wolters Kluwer. The risk is highest in men taking a type of BPH medication called alpha-blockers (ABs), rather than a different type called 5-alpha reductase inhibitors (5-ARIs), according to the new research by D. Robert Siemens, MD, and ...

Oncotarget: MEK is a promising target in the basal subtype of bladder cancer

Oncotarget: MEK is a promising target in the basal subtype of bladder cancer
2021-02-22
Oncotarget recently published in "MEK is a promising target in the basal subtype of bladder cancer" by Merrill, et al. which reported that while many resources exist for the drug screening of bladder cancer cell lines in 2D culture, it is widely recognized that screening in 3D culture is more representative of in vivo response. To address the need for 3D drug screening of bladder cancer cell lines, the authors screened 17 bladder cancer cell lines using a library of 652 investigational small-molecules and 3 clinically relevant drug combinations in 3D cell culture. Their goal was to identify compounds and classes of compounds with efficacy in bladder cancer. Utilizing ...

Biological assessment of world's rivers presents incomplete but bleak picture

Biological assessment of worlds rivers presents incomplete but bleak picture
2021-02-22
An international team of scientists, including two from Oregon State University, conducted a biological assessment of the world's rivers and the limited data they found presents a fairly bleak picture. "For the places that we have data, the situations are not really that good. There are many species that are declining, threatened or endangered," said Bob Hughes, co-author of the paper and a courtesy associate professor in Oregon State's Department of Fisheries and Wildlife. "But for most of the globe, there just is little rigorous data." The work by Hughes and the ...

LAST 30 PRESS RELEASES:

Why some coronavirus strains are more infectious than others

Scientists reveal details of antibodies that work against Zika virus

Scientists uncover new details of SARS-CoV-2 interactions with human cells

Antibodies recognize and attack different SARS-CoV-2 spike shapes

How SARS-CoV-2's sugar-coated shield helps activate the virus

A Canadian success story: world-first to treat Fabry disease with gene therapy

Chimpanzees and humans share overlapping territories

Allergy season starts earlier each year due to climate change and pollen transport

Study shows opioid use among US patients with knee osteoarthritis costs 14 billion dollars in societal costs

On the line: Watching nanoparticles get in shape

A-maze-ing pheasants have two ways of navigating

CAR T-cell therapy generates lasting remissions in patients with multiple myeloma

Fantastic voyage: Nanobodies could help CRISPR turn genes on and off

Baby mice have a skill that humans want - and this microchip might help us learn it

New discoveries on the containment of COVID-19 finds travel bans are of limited value

UM scientists achieve breakthrough in culturing corals and sea anemones cells

New shape-changing 4D materials hold promise for morphodynamic tissue engineering

Apollo rock samples capture key moments in the Moon's early history, study find

COVID-19 isolation linked to increased domestic violence, researchers suggest

What to do when a mammogram shows swollen lymph nodes in women just vaccinated for COVID

After Hurricane Irma, soundscape reveals resilient reef ecosystem

Parker Solar Probe offers stunning view of Venus

Ancient skeletal hand could reveal evolutionary secrets

Study finds human-caused North Atlantic right whale deaths are being undercounted

Bearded seals are loud -- but not loud enough

Tool that more efficiently analyzes ocean color data will become part of NASA program

Paleontologists discover new insect group after solving 150-year-old mystery

'Miracle poison' for novel therapeutics

Over 80% of Atlantic Rainforest remnants have been impacted by human activity

Researchers use machine learning to identify autism blood biomarkers

[Press-News.org] Oncotarget: MEK inhibitors relevant to SARS-CoV-2 infection
The @Oncotarget authors show a drug class-effect with MEKi to stimulate NK cells, inhibit inflammatory cytokines and block host-factors for SARS-CoV-2 infection leading also to suppression of SARS-CoV-2-S pseudovirus infection of human cells